Market underestimates potential of rising mid-cap stocks amid strategic shifts and strong results

Investing.com spotlights three undercovered mid-cap stocks, Rumble, Sellas Life Sciences, and ADMA Biologics, whose evolving business strategies and recent growth suggest they may be poised for a re-rating, despite thin analyst coverage. Investing.com has highlighted three lightly covered mid-cap stocks…













